Knight Therapeutics | GUD - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Acasti Pharma USD 75K 30K 2021-03
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Aurora Cannabis CAD 29.79M 16.83M 2026-03
Avita Medical AUD 14.31M 639K 2025-12
Canopy Growth CAD 8.26M 13.2M 2026-03
Cronos Group USD 16.19M 34.52M 2025-12
Dianthus Therapeutics USD 463K 179K 2026-03
Ionis Pharmaceuticals USD 243M 48M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Moderna USD -566M 792M 2026-03
Omeros USD -33.16M 18.52M 2024-06
Organigram Holdings CAD 16.41M 6.91M 2026-03
Organon & Co USD 783M 71M 2026-03
Revvity USD 387.66M 34M 2026-03
Tectonic Therapeutic USD 0 0 2025-03
Tilray USD 57.47M 10.16M 2025-06
Viatris USD 1.38B 229.9M 2026-03
Xeris Pharmaceuticals USD 72.55M 404K 2026-03